137 related articles for article (PubMed ID: 9819743)
1. Refractory Wegener's granulomatosis: a model for shorter immunotherapy of autoimmune diseases.
Lockwood CM
J R Coll Physicians Lond; 1998; 32(5):473-8. PubMed ID: 9819743
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies.
Lockwood CM; Thiru S; Stewart S; Hale G; Isaacs J; Wraight P; Elliott J; Waldmann H
QJM; 1996 Dec; 89(12):903-12. PubMed ID: 9015484
[TBL] [Abstract][Full Text] [Related]
3. Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade.
Kleinert J; Lorenz M; Köstler W; Hörl W; Sunder-Plassmann G; Soleiman A
Wien Klin Wochenschr; 2004 May; 116(9-10):334-8. PubMed ID: 15237661
[TBL] [Abstract][Full Text] [Related]
4. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
5. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
[TBL] [Abstract][Full Text] [Related]
6. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for refractory Wegener's granulomatosis.
Antoniu SA
Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
[TBL] [Abstract][Full Text] [Related]
8. Two cases of refractory Wegener's granulomatosis successfully treated with rituximab.
Tamura N; Matsudaira R; Hirashima M; Ikeda M; Tajima M; Nawata M; Morimoto S; Kaneda K; Kobayashi S; Hashimoto H; Takasaki Y
Intern Med; 2007; 46(7):409-14. PubMed ID: 17409608
[TBL] [Abstract][Full Text] [Related]
9. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener's granulomatosis.
Haubitz M; Koch KM; Brunkhorst R
Nephrol Dial Transplant; 1998 Jul; 13(7):1713-8. PubMed ID: 9681717
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Wegener's granulomatosis].
Riccieri V; Valesini G
Reumatismo; 2004; 56(2):69-76. PubMed ID: 15309213
[TBL] [Abstract][Full Text] [Related]
11. Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.
Specks U; Fervenza FC; McDonald TJ; Hogan MC
Arthritis Rheum; 2001 Dec; 44(12):2836-40. PubMed ID: 11762944
[TBL] [Abstract][Full Text] [Related]
12. High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide.
Benenson E; Fries JW; Heilig B; Pollok M; Rubbert A
Clin Rheumatol; 2005 Jun; 24(3):251-7. PubMed ID: 15940558
[TBL] [Abstract][Full Text] [Related]
13. Maintaining remission in a patient with vasculitis.
Flossmann O; Jayne DR
Nat Clin Pract Rheumatol; 2008 Sep; 4(9):499-504. PubMed ID: 18648340
[TBL] [Abstract][Full Text] [Related]
14. Rituximab induced remission in a patient with Wegener's granulomatosis.
Kallenbach M; Duan H; Ring T
Nephron Clin Pract; 2005; 99(3):c92-6. PubMed ID: 15665552
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled leucocyte imaging in diffuse granulomatous involvement of the meninges in Wegener's granulomatosis: scintigraphic findings and their role in monitoring treatment response to specific immunotherapy (humanized monoclonal antilymphocyte antibodies).
Murphy JM; Balan KK; Toms A; Gomez-Anson B; Lockwood M
AJNR Am J Neuroradiol; 2000 Sep; 21(8):1460-5. PubMed ID: 11003279
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
[TBL] [Abstract][Full Text] [Related]
17. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
Lockwood CM; Thiru S; Isaacs JD; Hale G; Waldmann H
Lancet; 1993 Jun; 341(8861):1620-2. PubMed ID: 8099991
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.
Schmitt WH; Hagen EC; Neumann I; Nowack R; Flores-Suárez LF; van der Woude FJ;
Kidney Int; 2004 Apr; 65(4):1440-8. PubMed ID: 15086487
[TBL] [Abstract][Full Text] [Related]
19. Deoxyspergualin in relapsing and refractory Wegener's granulomatosis.
Flossmann O; Baslund B; Bruchfeld A; Tervaert JW; Hall C; Heinzel P; Hellmich B; Luqmani RA; Nemoto K; Tesar V; Jayne DR
Ann Rheum Dis; 2009 Jul; 68(7):1125-30. PubMed ID: 18713783
[TBL] [Abstract][Full Text] [Related]
20. Wegener's granulomatosis effectively treated with rituximab: a case study.
Kowalewska B; Szechiński J; Roszkowska E
Pol Arch Med Wewn; 2008 Jun; 118(6):381-5. PubMed ID: 18619196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
